Overcoming Tumor Antigen Heterogeneity in the Context of CAR T Cell therapy for Solid Tumors

Dr Astero Klampatsa

Thoracic Oncology Immunotherapy Group, The Institute of Cancer Research, Division of Cancer Therapeutics, London, UK